B-ALL
Clinical trials for B-ALL explained in plain language.
Never miss a new study
Get alerted when new B-ALL trials appear
Sign up with your email to follow new studies for B-ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection shows promise for Hard-to-Treat leukemia
Disease control Recruiting nowThis early-stage study tests a new drug called KSV01 in 30 adults with a type of blood cancer (B-ALL) that has come back or not responded to standard treatments. The main goal is to check if the drug is safe and what side effects it may cause. Researchers will also look for early…
Matched conditions: B-ALL
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New combo therapy aims to boost CAR t-cell success in hard-to-treat blood cancers
Disease control Recruiting nowThis early-phase study tests a radioactive drug (131-I apamistamab) given before CAR T-cell therapy for people with relapsed or refractory B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma. The goal is to find a safe dose and see if the combination is tolerable…
Matched conditions: B-ALL
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New study aims to predict relapse after CAR T-Cell therapy in kids with leukemia
Knowledge-focused Recruiting nowThis study tests whether frequent blood and bone marrow tests can help doctors know if a child's leukemia will come back after CAR T-cell therapy. About 60 children and young adults (ages 1-25) who have no detectable cancer after CAR T will be followed for 2 years. The goal is to…
Matched conditions: B-ALL
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 01, 2026 14:18 UTC
-
New study tracks hidden risks of CAR t therapy in kids
Knowledge-focused Recruiting nowThis study follows 100 children and young adults who received CAR T-cell therapy to learn about side effects like infections, slow blood cell recovery, and nerve problems. Researchers want to understand how often these issues happen and how long they last. The goal is to improve …
Matched conditions: B-ALL
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC